Should I Buy ASPI? ASPI 2026 Analysis

Should You Buy ASP Isotopes Inc (ASPI) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion

Hold

Latest Price

5.820

1 Day change

11.51%

52 Week Range

14.490

Analysis Updated At

2026/02/04

Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

Not a good buy right now for an impatient buyer: trend and momentum are still bearish, and near-term stats suggest a higher chance of a dip next day.
Price is only slightly above first support (S1 ~~6.18); downside risk to S2 (~~5.53) is meaningful if support breaks.
Despite bullish options positioning and credible upside catalysts (helium/Renergen narrative, new analyst initiation), the chart setup does not yet confirm a turn; better odds come after reclaiming the pivot (~7.24) and improving momentum.

Technical Analysis

Pre-market price ~6.40 is below the pivot (7.244), keeping the stock in a technically weak zone.
Trend: bearish alignment (SMA_200 > SMA_20 > SMA_5) signals a sustained downtrend.
MACD histogram (-0.177) is below zero and expanding negatively → downside momentum is increasing.
RSI(6) ~34.84: approaching oversold but not showing a clear reversal signal yet.
Key levels: Support S1 ~6.183 (near current), then S2 ~5.527; Resistance pivot ~7.244, then R1 ~8.305.
Pattern-based forward look: ~80% chance of about -1.22% next day; but still positive bias over 1 week (+1.4%) and 1 month (+6.44%), implying “choppy near-term, better medium-term.”

Options Data

Bullish

Open Interest Put-Call Ratio

Bullish

Option Volume Put-Call Ratio

Positioning is strongly call-skewed (low put/call ratios), signaling bullish/speculative sentiment despite weak price momentum.
Implied volatility is very elevated (30D IV ~150.9; IV percentile ~75.2), meaning the market is pricing big moves (often around catalysts like earnings or deal updates).
Volume vs recent averages: today’s option volume is below the 30D average (~90.6% of avg), so sentiment is bullish but not a fresh volume “surge” signal.

Technical Summary

Sell

Buy

Positive Catalysts

- Renergen Helium Project update: reported +60% gas processing capacity and 80% drilling success rate since April 2025, supporting the commercialization narrative.
- Analyst coverage: Cantor Fitzgerald initiated Overweight with a $13 target, highlighting isotope-enrichment tech and potential value creation from corporate actions (acquisition/spinout narratives).
- Earnings catalyst ahead: Q earnings on 2026-02-18 after hours (can re-rate the stock quickly if commercialization traction shows).

Neutral/Negative Catalysts

- Technical/momentum headwind: news flags ASPI as having the lowest momentum rating, consistent with the bearish moving averages and MACD.
- Legal overhang: Halper Sadeh investigation into directors for potential fiduciary duty breaches can pressure sentiment until resolved (even if it sometimes leads to governance changes).
- Very high volatility regime (IV ~150%+) increases the chance of sharp drawdowns if any catalyst disappoints.
- No supportive “smart money” confirmation: hedge funds and insiders show neutral recent activity trends; no recent Congress trading data available.

Financial Performance

Latest quarter: 2025/Q3.
Revenue: $4.89M, up ~349.53% YoY (strong top-line growth off a small base).
Profitability: Net income still negative (-$12.87M), but improved ~77.05% YoY; EPS -$0.15 improved ~25% YoY.
Quality of growth concern: Gross margin fell to ~8.65% (down ~68% YoY), suggesting current revenue growth is not yet translating into strong economics.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Recent analyst trend: Cantor Fitzgerald initiated coverage (2025-12-04) with Overweight and a $13 price target; no other rating/target changes provided.
Wall Street pros view (from available data):
- Pros: unique isotope-enrichment positioning, potential helium asset/control narrative via Renergen, multiple “story” catalysts (acquisition/spinout/earnings).
- Cons: current fundamentals show ongoing losses and sharply lower gross margin; price action/momentum does not yet validate the bullish narrative.

3 Analyst Rating

Wall Street analysts forecast ASPI stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ASPI is 13 USD with a low forecast of 11 USD and a high forecast of 15 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

3 Buy

0 Hold

0 Sell

Strong Buy

Current: 5.215

Low

Averages

High

Current: 5.215

Low

Averages

High

Cantor Fitzgerald

Derek Soderberg

Overweight

initiated

$13

AI Analysis

2025-12-04

Reason

Cantor Fitzgerald

Derek Soderberg

Price Target

$13

AI Analysis

2025-12-04

initiated

Overweight

Reason

Cantor Fitzgerald analyst Derek Soderberg initiated coverage of ASP Isotopes (ASPI) with an Overweight rating and $13 price target. ASP Isotopes has developed advanced isotope-enrichment technology that produces high-value nuclear fuel, medical isotopes, and silicon-28, and currently stands as the sole commercial-scale provider of certain isotopes, the analyst tells investors in a research note. The pending acquisition of Renergen (RGNNF) could give ASPI control of the world's largest high-concentration helium deposit, while the planned spinout of its quantum laser enrichment technology represents a near-term value-creation opportunity, Cantor says.

Cantor Fitzgerald

Derek Soderberg

initiated

$13

2025-12-04

Reason

Cantor Fitzgerald

Derek Soderberg

Price Target

$13

2025-12-04

initiated

Reason

Cantor Fitzgerald analyst Derek Soderberg initiated coverage of ASP Isotopes with an Overweight rating and $13 price target.

Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for ASPI

Unlock Now

ASPI Should I Buy

ASPI Should I Buy

Should You Buy ASP Isotopes Inc (ASPI) Today? Analysis, Price Targets, and 2026 Outlook.

Technical Analysis

Options Data

Technical Summary

Positive Catalysts

Neutral/Negative Catalysts

Financial Performance

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

People Also Watch